Physician profile
Anthony E Rizzo
NPI 1437536422
$1,050.42
in general payments reported to CMS, 2019-2025
19 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.28 · 2023: $249 · 2024: $227 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $175.46 | 2025 | Hemoblast Bellows |
| Smith+Nephew, INC. | $134.76 | 2023 | Stravix Pl |
| Abbvie INC. | $131.24 | 2024-2025 | |
| Eisai INC. | $69.88 | 2022-2025 | |
| Genmab U.S., INC. | $66.69 | 2023-2025 | Tivdak |
| Astrazeneca Pharmaceuticals Lp | $61.87 | 2022-2024 | Lynparza |
| Coopersurgical, INC. | $59.98 | 2025 | Ally II Ups |
| Merck Sharp & Dohme LLC | $58.44 | 2024-2025 | Keytruda |
| Applied Medical Resources Corporation | $56.84 | 2023 | Gelpoint V-Path |
| Legend Biotech USA INC. | $36.46 | 2025 | Carvykti |
| E.R. Squibb & Sons, L.L.C. | $32.65 | 2023-2025 | Eliquis |
| Baxter Healthcare | $27.21 | 2024 | Perclot |
| Foundation Medicine, INC. | $24.08 | 2022 | |
| Caris Mpi, INC. | $22.72 | 2025 | Mi Cancer Seek |
| Takeda Pharmaceuticals U.S.A., INC. | $21.86 | 2025 | Gattex |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $20.13 | 2025 | Monjuvi, Zynyz |
| Janssen Biotech, INC. | $18.23 | 2025 | Darzalex, Talvey |
| United Therapeutics Corporation | $16.94 | 2025 | Tyvaso |
| Angiodynamics, INC. | $14.98 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.